UNSPSC 51182062: Nandrolone undecylate

This classification denotes a therapeutic androgen and anabolic steroid C29H46O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K64MCF1I9Z, chemically known as estr-4-en-3-one, 17-((1-oxoundecyl)oxy)-, (17.beta.)-, but more generally known as nandrolone undecylate, which bears US NIH Compound Identifier 94193. European Medicines Agency schedules Nandrolone undecylate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03388MIG.

Most nations, for tariff and trade purposes, schedule nandrolone undecylate under HS 29372900 and SITC 54153. As of Q4 2014, NANDROLONE UNDECYLATE remains US FDA's Preferred Term for this commodity. Nandrolone undecylate bears US NLM identifiers UMLS ID C0068398 and NCI Concept Code C95974. SMILES: CCCCCCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C.

UNSPSC 51182062 Nandrolone undecylate is a Commodity code that sits at the narrowest tier of the taxonomy and names a specific pharmaceutical compound — an anabolic steroid used in clinical and veterinary medicine. The source provides no records of recent state and local contract opportunities soliciting this product, and thus no concrete framing of active procurement activity, issuing-body engagement, or geographic spread under this code.

State and local procurement offices do not appear to be actively buying nandrolone undecylate at present, or opportunities solicited under this code are not being captured in the available datasets.